Cargando…

DNMT3A mutations in Chinese childhood acute myeloid leukemia

BACKGROUND: DNA methyltransferase 3A (DNMT3A) mutations have been found in approximately 20% of adult acute myeloid leukemia (AML) patients and in 0% to 1.4% of children with AML, and the hotspots of mutations are mainly located in the catalytic methyltransferase domain, hereinto, mutation R882 acco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Weijing, Cui, Lei, Gao, Chao, Liu, Shuguang, Zhao, Xiaoxi, Zhang, Ruidong, Zheng, Huyong, Wu, Minyuan, Li, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626129/ https://www.ncbi.nlm.nih.gov/pubmed/28767575 http://dx.doi.org/10.1097/MD.0000000000007620

Ejemplares similares

Quantitative monitoring of minimal residual disease in childhood acute lymphoblastic leukemia using TEL‐AML1 fusion transcript as a marker
por: Zhao, Xiaoxi, et al.
Publicado: (2019)

Correction to: DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells
por: Li, Weijing, et al.
Publicado: (2023)

Alkaloid-based regimen is beneficial for acute myeloid leukemia resembling acute promyelocytic leukemia with NUP98/RARG fusion and RUNX1 mutation: A case report
por: Wei, Wei, et al.
Publicado: (2020)

The prognostic value of the peripheral blood cell counts changes during induction chemotherapy in Chinese patients with adult acute myeloid leukemia
por: Huang, Yuan-Mao, et al.
Publicado: (2021)

Transformation from acute promyelocytic leukemia to acute myeloid leukemia with a CEBPA double mutation: A case report and review of the literature
por: Sun, Ye, et al.
Publicado: (2021)

Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey: A single-center study
por: Merdin, Alparslan, et al.
Publicado: (2021)

Sedation and Analgesia With Fentanyl and Etomidate for Intrathecal Injection in Childhood Leukemia Patients
por: Yang, Chun-Hui, et al.
Publicado: (2015)

DNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 Patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2016)

Double remission of chronic lymphocytic leukemia and secondary acute myeloid leukemia after venetoclax monotherapy: A case report
por: Wang, Lei, et al.
Publicado: (2021)

Pulmonary hypertension in patients with chronic myeloid leukemia
por: Song, Ik-Chan, et al.
Publicado: (2021)

Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia
por: Xue, Hongjuan, et al.
Publicado: (2021)

DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells
por: Li, Weijing, et al.
Publicado: (2023)

Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report
por: Li, Xiang, et al.
Publicado: (2020)

The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and TLS-ERG gene fusion: A case report
por: Gao, Lu, et al.
Publicado: (2022)

Case Report of acute myeloid leukemia with “WT1, ATRX, CEBPA, CSMD1, IKZF1, and LRP1B mutation and translocation between chromosome 1 and 19” developing from Philadelphia-negative chronic myeloid leukemia after TKI therapy
por: Zhu, Huan, et al.
Publicado: (2020)

Transformation from acute promyelocytic leukemia in pregnancy to acute myeloid leukemia with MLL-AF9 fusion gene: A case report and literature review
por: Gao, Yang, et al.
Publicado: (2023)

Acute myeloid leukemia presenting as erythema nodosum: A case report
por: Xu, Xiaohan, et al.
Publicado: (2017)

Anxiety and depression predict unfavorable survival in acute myeloid leukemia patients
por: Ding, Ting, et al.
Publicado: (2019)

Management of chronic myeloid leukemia presenting with isolated thrombocytosis and complex Philadelphia chromosome: A case report
por: Gao, Lu, et al.
Publicado: (2021)

MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B
por: Chen, Yimin, et al.
Publicado: (2021)

Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations
por: Merdin, Alparslan, et al.
Publicado: (2020)

Dasatinib associated lymphadenopathy in a chronic myeloid leukemia patient: A case report
por: Pilalas, Dimitrios, et al.
Publicado: (2020)

Identification of the hub genes and pathways involved in acute myeloid leukemia using bioinformatics analysis
por: Tan, Youping, et al.
Publicado: (2020)

First-line treatment failure in childhood acute lymphoblastic leukemia: The polish pediatric leukemia and lymphoma study group experience
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

Genetic polymorphisms of NAT2 and risk of acute myeloid leukemia: A case-control study
por: Zou, Yunding, et al.
Publicado: (2017)

Clinical features and outcomes of hypocellular acute myeloid leukemia in adults: A Korean AML registry data
por: Song, Ik-Chan, et al.
Publicado: (2021)

Intermediate dose cytarabine improves survival and relapse-free rate compared with standard-dose cytarabine as post-remission treatment for acute myeloid leukemia: A retrospection study
por: Ye, Li, et al.
Publicado: (2021)

Pure erythroid leukemia subsequent to acute myelomonocytic leukemia: A case report
por: Ji, Jiamei, et al.
Publicado: (2021)

Chest radiographic and CT findings in hyperleukocytic acute myeloid leukemia: A retrospective cohort study of 73 patients
por: Stefanski, Michael, et al.
Publicado: (2016)

An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China: A CHEERS-compliant article
por: Wu, Bin, et al.
Publicado: (2017)

Combination of DNA-hypomethylating agent and hematopoietic stem cell transplantation in treatment of juvenile myelomonocytic leukemia: A case report
por: Ai, Yuan, et al.
Publicado: (2020)

Venetoclax + hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia: Two case reports
por: Wang, Hongxia, et al.
Publicado: (2020)

The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China
por: Gu, Mianmian, et al.
Publicado: (2019)

Clinical efficacy and safety of imatinib treatment in children and adolescents with chronic myeloid leukemia: A single-center experience in China
por: Deng, Mengyue, et al.
Publicado: (2020)

Polyserositis as a primary clinical manifestation of CD7+ acute myelogenous leukemia with myeloid sarcoma: A case report
por: Pi, Yubo, et al.
Publicado: (2020)

Cladribine, cytarabine, and filgrastim based regimen in relapsed or refractory acute myeloid leukemia: A systematic review and meta-analysis
por: Cao, Susu, et al.
Publicado: (2023)

Does High-Dose Cytarabine Cause More Fungal Infection in Patients With Acute Myeloid Leukemia Undergoing Consolidation Therapy: A Multicenter, Prospective, Observational Study in China
por: Wang, Ling, et al.
Publicado: (2016)

Relapsed/refractory acute promyelocytic leukemia with RARA-LBD region mutation was salvaged by venetoclax: A case report
por: Li, Youli, et al.
Publicado: (2021)

Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia
por: Zhang, Wenjun, et al.
Publicado: (2014)

Prognostic impact of viral reactivations in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation in first complete response
por: Guenounou, Sarah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3sq9lm1gbj074gdre2oes4e14i